Beta Source Dosimetry for Brachytherapy of Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is the leading cause of blindness in aging adults and affects millions of patients in the U.S. and even more worldwide. Existing treatments of the most devastating neovascular form of AMD involve monthly injections into the eye(s) of patients, who typically are elderly. These injections are costly and burdensome, requiring periodic intraocular injections for drug delivery. Radiation has been used to treat AMD: 6 MV external-beam radiation irradiation, proton therapy, and most recently stereotactic x-rays and beta applicators.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research